Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-14

Clinical Trial Update: Safety and Efficacy of a Natural Health Product in Reducing Cholesterol and Triglyceride Levels. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trial evaluating a natural health product for safety and efficacy in lowering LDL cholesterol and triglycerides has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Natural Health Product (unspecified)

Snippet

Sponsor: Nordic Pharma, USA | Conditions: LDL Cholesterol, Triglycerides | Phase 1, Phase 2 | Status: COMPLETED